Jason Liwen Huang
The Chinese University of Hong Kong
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jason Liwen Huang.
The American Journal of Gastroenterology | 2017
Jason Liwen Huang; Yingxu Wang; Johnny Y. Jiang; Chun Pong Yu; Yunlin Wu; Ping Chen; Xiaoqin Yuan; Harry H.X. Wang; Martin C.S. Wong
Objectives:Whether screening participants with distal hyperplastic polyps (HPs) detected by flexible sigmoidoscopy (FS) should be followed by subsequent colonoscopy is controversial. We evaluated the association between distal HPs and proximal neoplasia (PN)/advanced proximal neoplasia (APN) in asymptomatic, average-risk patients.Methods:We searched Ovid Medline, EMBASE, and the Cochrane Library from inception to 30 June 2016 and included all screening studies that examined the relationship between different distal findings and PN/APN. Data were independently extracted by two reviewers with disagreements resolved by a third reviewer. We pooled absolute risks and odds ratios (ORs) with a random effects meta-analysis. Seven subgroup analyses were performed according to study characteristics. Heterogeneity was characterized with the I2 statistics.Results:We analyzed 28 studies (104,961 subjects). When compared with normal distal findings, distal HP was not associated with PN (OR=1.16, 95% confidence interval (CI)=0.89–1.51, P=0.14, I2=40%) or APN (OR=1.09, 95% CI=0.87–1.36, P=0.39, I2=5%), while subjects with distal non-advanced or advanced adenoma had higher odds of PN/APN. Higher odds of PN/APN were observed for more severe distal lesions. Weaker association between distal and proximal findings was noticed in studies with higher quality, larger sample size, population-based design, and more stringent endoscopy quality-control measures. The Egger’s regression tests showed all P>0.05.Conclusions:Distal HP is not associated with PN/APN in asymptomatic screening population when compared with normal distal findings. Hence, the presence of distal HP alone detected by FS does not automatically indicate colonoscopy referral for all screening participants, as other risk factors of PN/APN should be considered.
Scientific Reports | 2017
Jason Liwen Huang; Ping Chen; Xiaoqin Yuan; Yunlin Wu; Harry H.X. Wang; Martin C.S. Wong
This study aims to develop and validate a new algorithm that incorporates distal colonoscopic findings to predict advanced proximal neoplasia (APN) in a Chinese asymptomatic population. We collected age, gender, and colonoscopic findings from a prospectively performed colonoscopy study between 2013 and 2015 in a large hospital-based endoscopy unit in Shanghai, China. Eligible subjects were allocated to a derivation group (n = 3,889) and validation group (n = 1,944) by random sampling. A new index for APN and its cut-off level were evaluated from the derivation cohort by binary logistic regression. The model performance was tested in the validation cohort using area under the curve (AUC). Age, gender, and distal finding were found to be independent predictors of APN in the derivation cohort (p < 0.001). Subjects were categorized into Average Risk (AR) and High Risk (HR) based on a cut-off score of 2. The AUC of the derivation and validation cohorts were 0.801 (0.754–0.847) and 0.722 (0.649–0.794), respectively. In the validation cohort, those in the HR group had a 3.57 fold higher risk of APN when compared with the AR group (P < 0.001), requiring 18 (95% CI = 12–28) follow-up colonoscopies to detect 1 APN. This new clinical index is useful to stratify APN risk in Chinese population.
The American Journal of Gastroenterology | 2018
Martin C.S. Wong; Chun Hei Chan; Jiayan Lin; Jason Liwen Huang; Junjie Huang; Yuan Fang; Wilson Cheung; Chun Pong Yu; John C. Wong; Gary Tse; Justin C. Wu; Francis K.L. Chan
OBJECTIVES: Existing algorithms predicting the risk of colorectal cancer (CRC) assign a fixed score for family history of CRC. Whether the increased CRC risk attributed to family history of CRC was higher in younger patients remains inconclusive. We examined the risk of CRC associated with family history of CRC in first‐degree relative (FDR) according to the age of index subjects (<40 vs. ≥40; <50 vs. ≥50; and <60 vs. ≥60 years). METHODS: Ovid Medline, EMBASE, and gray literature from the reference lists of all identified studies were searched from their inception to March 2017. We included case‐control/cohort studies that investigated the relationship between family history of CRC in FDR and prevalence of CRC. Two reviewers independently selected articles according to the PRISMA guideline. A random effects meta‐analysis pooled relative risks (RR). RESULTS: We analyzed 9.28 million subjects from 63 studies. A family history of CRC in FDR confers a higher risk of CRC (RR = 1.76, 95% CI = 1.57‐1.97, p < 0.001). This increased risk was higher in younger individuals (RR = 3.29, 95% CI = 1.67‐6.49 for <40 years versus RR = 1.42, 95% CI = 1.24‐1.62 for ≥40 years, p = 0.017; RR = 2.81, 95% CI = 1.94‐4.07 for <50 years versus RR = 1.47, 95% CI = 1.28‐1.69 for ≥50 years, p = 0.001). No publication bias was identified, and the findings are robust in subgroup analyses. CONCLUSIONS: The increase in relative risk of CRC attributed to family history was found to be higher in younger individuals. Family history of CRC could be assigned a higher score for younger subjects in CRC risk prediction algorithms. Future studies should examine if such approach may improve their predictive capability.
PLOS ONE | 2018
Yuan Fang; Harry H.X. Wang; Miaoyin Liang; Ming Sze Yeung; Colette Leung; Chun Hei Chan; Wilson Cheung; Jason Liwen Huang; Junjie Huang; Regina W.S. Sit; Samuel Y. S. Wong; Martin C.S. Wong
Background The Hong Kong Government released a Reference Framework (RF-HT) for Hypertension Care for Adults in Primary Care Settings since 2010. No studies have evaluated its adoption by primary care physicians (PCPs) since its release. Aim We aimed to evaluate the level of PCPs’ adoption of the RF-HT and the potential barriers of its use in family practice. Design and setting A cross-sectional study was conducted by a self-administered validated survey among all PCPs in Hong Kong through various means. Methods We assessed the level of and factors associated with its adoption by multivariate logistic regression modelling. Result A total of 3,857 invitation episodes were sent to 2,297 PCPs in 2014–2015. We received 383 completed questionnaires. The average score of adoption was 3.43 out of 4.00, and 47.5% of PCPs highly adopted RF-HT in their daily consultations. Male practitioners (adjusted odds ratio [aOR] = 0.524, 95% CI = 0.290–0.948, p = 0.033) and PCPs of public sector (aOR = 0.524, 95% CI = 0.292–0.940, p = 0.030) were significantly less likely to adopt the RF-HT. PCPs with higher training completion or being academic fellow are more likely to adopt RF-HT than those who were “nil to basic training completion” (aOR = 0.479, 95% CI = 0.269–0.853, p = 0.012) or “higher trainee” (aOR = 0.302, 95% CI = 0.093–0.979, p = 0.046). Three most-supported suggestions on RF-HT improvement were simplification of RF-HT, provision of pocket version and promoting in patients. Conclusion Among PCP respondents, the adoption level of the RF-HT was high. These findings also highlighted some factors associated with its adoption that could inform targeted interventions for enhancing its use in clinical practice.
Journal of Gastroenterology and Hepatology | 2018
Ping Chen; Jason Liwen Huang; Xiaoqin Yuan; Junjie Huang; Harry H.X. Wang; Gary Tse; Martin C.S. Wong; Yunlin Wu
A proper colonoscopy referral criterion is essential for flexible sigmoidoscopy‐based colorectal cancer screening. We aimed to compare the predictive capability of four existing criteria to detect proximal neoplasia (PN) and advanced proximal neoplasia (APN) in a Chinese population.
aimsph 2017, Vol. 4, Pages 289-300 | 2017
Jason Liwen Huang; Yuan Fang; Miaoyin Liang; Shannon T.S. Li; Simpson K.C. Ng; Zero Hui; Jessica Ching; Harry H.X. Wang; Martin Chi Sang Wong
Background Despite the proven effectiveness of colorectal cancer (CRC) screening on reduction of CRC mortality, the uptake of CRC screening remains low. Participation rate is one of determinants for the success of organized population-based screening program. This review aims to identify those who are hard-to-reach, and summarize the strategies to increase their screening rate from individual, provider and system levels. Methods A systematic search of electronic English databases was conducted on the factors and strategies of uptake in CRC screening for the hard-to-reach population up to May 2017. Discussion The coverage rate and participation rate are two indexes to identify the hard-to-reach population in organized CRC screening program. However, the homeless, new immigrants, people with severe mental illness, the jail intimates, and people with characteristics including lower education levels and/or low socioeconomic status, living in rural/remote areas, without insurance, and racial minorities are usually recognized as hard-to-reach populations. For them, organized screening programs offer a better coverage, while novel invitation approaches for eligible individuals and multiple strategies from primary care physicians are still needed to enhance screening rates among subjects who are hard-to-reach. Suggestions implied the effectiveness of interventions at the system level, including linkages to general practice; use of decision making tools; enlisting supports from coalition; and the continuum from screening to diagnosis and treatment. Conclusion Organized CRC screening offers a system access to approach the hard-to-reach populations. To increase their uptake, multiple and novel strategies from individual, provider and system levels should be applied. For policymakers, public healthcare providers and community stakeholders, it is a test to tailor their potential needs and increase their participation rates through continuous efforts to eliminate disparities and inequity in CRC screening service.
The Lancet | 2016
Jason Liwen Huang; Ping Chen; Xiaoqin Yuan; Yunlin Wu; Harry H.X. Wang; Johnny Y Jiang; Martin C.S. Wong
European Journal of Epidemiology | 2018
Martin C.S. Wong; Chun-hei Chan; Wilson Cheung; Din-hei Fung; Miaoyin Liang; Jason Liwen Huang; Yanhong Wang; Johnny Y Jiang; Chun-pong Yu; Harry Haoxiang Wang; Justin C. Wu; Francis Ka-Leung Chan; Joseph Jao Yiu Sung
Clinical Gastroenterology and Hepatology | 2017
Jason Liwen Huang; Ping Chen; Xiaoqin Yuan; Yunlin Wu; Harry Haoxiang Wang; Martin C.S. Wong
The Lancet | 2018
Junjie Huang; Jason Liwen Huang; Jingxuan Wang; Vincent C.H. Chung; Martin C.S. Wong